Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD)

被引:0
|
作者
van Son, Koen C. [1 ,2 ,3 ]
van Dijk, Anne-Marieke [1 ,2 ]
Driessen, Stan [1 ,2 ]
Mak, Anne Linde [1 ]
Witjes, Julia J. [1 ]
Houttu, Veera A. T. [1 ]
Zwirs, Diona [1 ]
Nieuwdorp, Max [1 ]
van den Born, Bert-Jan H. [1 ,4 ]
Fischer, Johan C. [5 ]
Tushuizen, Maarten E. [6 ]
Drenth, Joost P. H. [3 ]
Hamer, Henrike M. [5 ]
Beuers, Ulrich H. W. [3 ]
Verheij, Joanne [2 ,7 ]
Holleboom, Adriaan Georgius [1 ]
机构
[1] Amsterdam UMC, Locat AMC, Dept Vasc Med, Meibergdreef 9, Amsterdam, Netherlands
[2] Amsterdam Gastroenterol Endocrinol Metab AGEM Inst, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[3] Amsterdam UMC, Dept Gastroenterol & Hepatol, Locat AMC, Meibergdreef 9, Amsterdam, Netherlands
[4] Dept Publ & Occupat Hlth, Amsterdam UMC, Locat AMC, Amsterdam, Netherlands
[5] Univ Amsterdam, Dept Lab Med, Lab Specialized Diagnost & Res, Amsterdam UMC, Amsterdam, Netherlands
[6] Dept Gastroenterol & Hepatol, LUMC, Leiden, Netherlands
[7] Amsterdam UMC, Locat AMC, Dept Pathol, Amsterdam, Netherlands
关键词
metabolic dysfunction-associated steatotic liver disease (MASLD); advanced liver fibrosis; enhanced liver fibrosis (ELF)-test; reflex testing; diagnostic algorithms;
D O I
10.1515/cclm-2024-0470
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:e236 / e239
页数:4
相关论文
共 50 条
  • [1] THE PROGNOSTIC ROLE OF THE ELF TEST, COMPARED TO LIVER BIOPSY, IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Nicholas, V.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Pizzolante, F.
    De, Matthaeis N.
    Zocco, M. A.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Pompili, M.
    Rapaccini, G. L.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S257 - S257
  • [2] PROGNOSTIC SIGNIFICANCE OF ELF TEST COMPARED TO LIVER BIOPSY IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Galletti, Simone
    Cardinali, Sara
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Rapaccini, Gian Ludovico
    Pompili, Maurizio
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    HEPATOLOGY, 2024, 80 : S662 - S662
  • [3] Prognostic significance of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, Antonio
    D'Ambrosio, Francesca
    Viceconti, Nicholas
    Termite, Fabrizio
    Petrucci, Lucrezia
    Beschi, Riccardo
    Orienti, Marco
    Cardinali, Sara
    Galletti, Simone
    Riccardi, Laura
    Pizzolante, Fabrizio
    De Matthaeis, Nicoletta
    Ainora, Maria Elena
    Zocco, Maria Assunta
    Giustiniani, Maria Cristina
    Marrone, Giuseppe
    Biolato, Marco
    Vecchio, Fabio Maria
    Grieco, Antonio
    Urbani, Andrea
    Sanguinetti, Maurizio
    Gasbarrini, Antonio
    Miele, Luca
    JOURNAL OF HEPATOLOGY, 2024, 80 : S533 - S533
  • [4] Prognostic role of ELF test compared to liver biopsy in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)
    Liguori, A.
    D'Ambrosio, F.
    Viceconti, N.
    Termite, F.
    Petrucci, L.
    Beschi, R.
    Orienti, M.
    Galletti, S.
    Cardinali, S.
    Riccardi, L.
    Garcovich, M.
    Pizzolante, F.
    De Matthaeis, N.
    Zocco, M. A.
    Ainora, M. E.
    Giustiniani, M. C.
    Marrone, G.
    Biolato, M.
    Cefalo, C.
    Vecchio, F. M.
    Grieco, A.
    Urbani, A.
    Sanguinetti, M.
    Gasbarrini, A.
    Miele, L.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S12 - S12
  • [5] INSULIN RESISTANCE IS A PREDICTOR OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) AND MASLD-ASSOCIATED FIBROSIS
    Kim, David S.
    Ismail, Mohamed
    Abboud, Yazan
    Khan, Wajiha
    Le, Alexander
    Pyrsopoulos, Nikolaos T.
    Kim, Hyunseok
    Hajifathalian, Kaveh
    GASTROENTEROLOGY, 2024, 166 (05) : S1657 - S1657
  • [6] Evolutionary aspects of metabolic dysfunction-associated steatotic liver disease (MASLD)
    Geier, Andreas
    Schiffels, Stephan
    Krawczyk, Marcin
    GASTROENTEROLOGIE, 2025,
  • [7] Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Italian women: is liver fibrosis independent from menopause?
    Chen, R.
    Salamone, A.
    Abbati, C.
    Capelli, R.
    Santangeli, E.
    Stefanini, B.
    Indre, M. G.
    Ravaioli, F.
    Piscaglia, F.
    Ferri, S.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [8] Comparison of Referral Rates and Costs Using Fibrosis-4 and Enhanced Liver Fibrosis (ELF) Testing Strategies for Initial Evaluation of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in a Veteran Population
    Yeramaneni, Samrat
    Chang, Stephanie T.
    Cheung, Ramsey C.
    Chalfin, Donald B.
    Sangha, Kinpritma
    Levy, H. Roma
    Boltyenkov, Artem T.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2025,
  • [9] Roles of Activin A and Gpnmb in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Liu, Huan
    Yerevanian, Armen
    Westerhoff, Maria
    Hastings, Margaret H.
    Guerra, Justin Ralph Baldovino
    Zhao, Meng
    Svensson, Katrin J.
    Cai, Bishuang
    Soukas, Alexander A.
    Rosenzweig, Anthony
    DIABETES, 2024, 73 (02) : 260 - 279
  • [10] Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)
    Iturbe-Rey, Santiago
    Maccali, Claudia
    Arrese, Marco
    Aspichueta, Patricia
    Oliveira, Claudia P.
    Castro, Rui E.
    Lapitz, Ainhoa
    Izquierdo-Sanchez, Laura
    Bujanda, Luis
    Perugorria, Maria J.
    Banales, Jesus M.
    Rodrigues, Pedro M.
    ATHEROSCLEROSIS, 2025, 400